BRPI0617511A2 - Conjugado de peptídeo-imunoglobulina - Google Patents

Conjugado de peptídeo-imunoglobulina

Info

Publication number
BRPI0617511A2
BRPI0617511A2 BRPI0617511-2A BRPI0617511A BRPI0617511A2 BR PI0617511 A2 BRPI0617511 A2 BR PI0617511A2 BR PI0617511 A BRPI0617511 A BR PI0617511A BR PI0617511 A2 BRPI0617511 A2 BR PI0617511A2
Authority
BR
Brazil
Prior art keywords
peptide
immunoglobulin conjugate
immunoglobulin
conjugate
Prior art date
Application number
BRPI0617511-2A
Other languages
English (en)
Inventor
Stephan Fischer
Erhard Kopetzki
Suryanarayana Sankuratri
Ralf Schumacher
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35809600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0617511(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0617511A2 publication Critical patent/BRPI0617511A2/pt
Publication of BRPI0617511A8 publication Critical patent/BRPI0617511A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0617511A 2005-10-21 2006-10-19 conjugado de peptídeo-imunoglobulina BRPI0617511A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05023002 2005-10-21
PCT/EP2006/010061 WO2007045463A1 (en) 2005-10-21 2006-10-19 A peptide-immunoglobulin-conjugate

Publications (2)

Publication Number Publication Date
BRPI0617511A2 true BRPI0617511A2 (pt) 2015-07-07
BRPI0617511A8 BRPI0617511A8 (pt) 2018-04-24

Family

ID=35809600

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0617511A BRPI0617511A8 (pt) 2005-10-21 2006-10-19 conjugado de peptídeo-imunoglobulina

Country Status (13)

Country Link
US (1) US20070148180A1 (pt)
EP (1) EP1940882A1 (pt)
JP (1) JP2009512655A (pt)
KR (1) KR20080070014A (pt)
CN (1) CN101291956A (pt)
AR (1) AR056137A1 (pt)
AU (1) AU2006303438A1 (pt)
BR (1) BRPI0617511A8 (pt)
CA (1) CA2625332A1 (pt)
IL (1) IL190552A0 (pt)
NO (1) NO20081704L (pt)
TW (1) TW200722436A (pt)
WO (1) WO2007045463A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200817438A (en) 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
PE20081140A1 (es) 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
EP2162540A2 (en) 2007-05-22 2010-03-17 Amgen Inc. Compositions and methods for producing bioactive fusion proteins
PT2592148T (pt) 2007-10-12 2018-11-12 Hoffmann La Roche Expressão proteica de múltiplos ácidos nucleicos
CA2755336C (en) 2009-03-20 2015-07-14 Amgen Inc. Carrier immunoglobulins and uses thereof
US20120231006A1 (en) 2009-11-20 2012-09-13 Amgen Inc. Anti-orai1 antigen binding proteins and uses thereof
AU2011289426A1 (en) 2010-08-10 2013-02-28 Amgen Inc. Dual function in vitro target binding assay for the detection of neutralizing antibodies against target antibodies
MX360946B (es) 2010-09-22 2018-10-29 Amgen Inc Star Inmunoglobulinas portadoras y usos de las mismas.
JP2014507136A (ja) 2011-01-18 2014-03-27 アムジエン・インコーポレーテツド ＮａＶ１．７ノックアウトマウスとそれらの使用
HK1202587A1 (en) * 2011-12-15 2015-10-02 The Royal Institution For The Advancement Of Learning/Mcgill University Soluble igf receptor fc fusion proteins and uses thereof
AU2013222188A1 (en) 2012-02-22 2014-09-11 Amgen Inc. Autologous mammalian models derived from induced pluripotent stem cells and related methods
MX377591B (es) 2014-10-15 2025-03-10 Amgen Inc Elementos promotores y reguladores para mejorar la expresión de genes heterólogos en células hospederas.
WO2018132768A1 (en) 2017-01-13 2018-07-19 Sanna Pietro P Methods and compositions for treating hpa hyperactivity
WO2019066603A1 (ko) * 2017-09-29 2019-04-04 한미약품 주식회사 효력이 향상된 지속성 단백질 결합체

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5567584A (en) * 1988-01-22 1996-10-22 Zymogenetics, Inc. Methods of using biologically active dimerized polypeptide fusions to detect PDGF
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
ATE311895T1 (de) * 1992-05-26 2005-12-15 Immunex Corp Neue zytokine die cd30 binden
US6620413B1 (en) * 1995-12-27 2003-09-16 Genentech, Inc. OB protein-polymer chimeras
WO1997044461A2 (en) * 1996-05-22 1997-11-27 Novopharm Biotech, Inc. Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
US6656906B1 (en) * 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
US6258782B1 (en) * 1998-05-20 2001-07-10 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
CA2416656A1 (en) * 2000-06-05 2002-04-04 University Of Tennessee Corporation Compositions and methods for the endocytic presentation of immunosuppressive factors
US20030077826A1 (en) * 2001-02-02 2003-04-24 Lena Edelman Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
AU2004313242A1 (en) * 2004-01-07 2005-07-28 Trimeris, Inc. HIV gp41 HR2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus

Also Published As

Publication number Publication date
EP1940882A1 (en) 2008-07-09
AR056137A1 (es) 2007-09-19
WO2007045463A1 (en) 2007-04-26
IL190552A0 (en) 2008-11-03
CA2625332A1 (en) 2007-04-26
NO20081704L (no) 2008-06-05
KR20080070014A (ko) 2008-07-29
JP2009512655A (ja) 2009-03-26
US20070148180A1 (en) 2007-06-28
TW200722436A (en) 2007-06-16
AU2006303438A1 (en) 2007-04-26
BRPI0617511A8 (pt) 2018-04-24
CN101291956A (zh) 2008-10-22

Similar Documents

Publication Publication Date Title
DK1928882T3 (da) (s)-n-methylnaltrexon
EP1855738A4 (en) CATHETER CONNECTOR
ATE408603T1 (de) Pyrazolylcarboxanilide
CR9974A (es) Gavión
DE502006003394D1 (de) Lehnenklappung
EP1893244A4 (en) AGENTS FOR IMAGING
DE502006005667D1 (de) Gelenklager
DK1943406T3 (da) Byggeelement
EP1942232A4 (en) Construct
ATE549324T1 (de) Tetrahydrobenzoxazine
BRPI0617511A8 (pt) conjugado de peptídeo-imunoglobulina
EP1916896A4 (en) NOT STEROID-antiandrogens
DE502006004302D1 (de) Verschlusskappe
DE502005005839D1 (de) Feldgeerät
DE502006001397D1 (de) Lagerbuchse
DE102005052834B8 (de) Punktschweißklebverbindung
DE502006001004D1 (de) Hydrolager
DE502006006589D1 (de) Teils
ATE485368T1 (de) Hiv - impfung
AT501523A3 (de) Estrich
DE502006003147D1 (de) Verbundgußplatte
PT1889059E (pt) Métodos de imunoensaio melhorados
DE602006007836D1 (de) Kontrastmittel
DE502006000445D1 (de) Mulchmähdeck
DE502006003210D1 (de) Nohydrogenpolysiloxanen

Legal Events

Date Code Title Description
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]

Free format text: APRESENTE NOVAS VIAS DE DESENHOS, SEM CORES, CONFORME DETERMINA O ITEM 15.1.4.1 (B) DO AN NO 127/1997.

B12C Appeal against dismissal [chapter 12.3 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]